Current report no. 2023/10/1

BS Biotechna S.A. has signed an agreement with the Medical Research Agency for the implementation and co-financing of the project ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’.